Global Specimen Collection Cards Market to Grow with a CAGR of 4.72% through 2028
Increasing emphasis on non-invasive procedures
and initiatives taken by the government are the major drivers for the Global
Specimen Collection Cards Market.
According to TechSci Research report, “Global
Specimen Collection Cards Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2018-2028”, the Global
Specimen Collection Cards Market stood at USD 434.34 million in 2022 and is
anticipated to project steady growth in the forecast period with a CAGR of 4.72%
through 2028. This can be ascribed to collaborations and partnerships among
leading companies with a diverse approach to merge the expertise of individual
companies and to strengthen their position in the market.
A specimen refers to a sample or
representative portion of a substance, material, or biological entity that is
collected, observed, examined, or analyzed for various purposes, such as
research, testing, diagnosis, or study. Specimens are commonly used in
scientific, medical, and research contexts to gain insights, make observations,
and draw conclusions about the properties, characteristics, or nature of the
larger whole from which the specimen is taken. Specimen collection cards are
used to collect, transport, and preserve biological samples for various
diagnostic, research, and screening purposes. They offer several advantages over
traditional sample collection methods, especially in scenarios where
convenience, ease of use, and sample stability are important factors. Specimen
collection cards are designed to preserve the integrity of biological samples,
including DNA, RNA, proteins, and other biomolecules.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Specimen Collection Cards Market.”
The materials and
stabilizers used in these cards help prevent degradation and maintain the
quality of the samples over time. Specimen collection cards require only a
small amount of the sample, which makes the collection process minimally
invasive and less uncomfortable for patients. This can lead to greater
acceptance and willingness to undergo testing. Specimen collection cards
require only a small amount of the sample, which makes the collection process
minimally invasive and less uncomfortable for patients. This can lead to
greater acceptance and willingness to undergo testing, which is a growth driver
for the market. Traditional sample collection methods, such as venipuncture
(blood draw) or other invasive procedures, can be uncomfortable or even painful
for some patients.
Specimen collection cards offer a less intrusive option,
enhancing patient comfort. Due to their ease of use and reduced invasiveness,
specimen collection cards can lead to higher patient compliance with recommended
testing regimens. Patients are more likely to follow through with testing when
it is convenient and less intimidating, which further results in market growth.
Specimen collection cards are particularly advantageous for pediatric and
geriatric patients, who may find traditional sample collection methods
distressing or difficult to tolerate.
However, public perception and acceptance
can indeed be a challenge in the specimen collection cards market. Specimen
collection cards might be relatively new to some patients and healthcare
professionals. This lack of familiarity can lead to skepticism or hesitation in
adopting these cards as a reliable sample collection method. Some individuals
and healthcare providers might prefer traditional sample collection methods
that they are more accustomed to, even if these methods are more invasive or
less convenient. Patients and healthcare providers may question whether
specimen collection cards can provide accurate results, particularly for
sensitive diagnostic tests. Healthcare providers' willingness to recommend and
utilize specimen collection cards can greatly influence patient acceptance. If
providers are unfamiliar with or hesitant about using these cards, patients
might share those sentiments. Emerging markets and improved healthcare access
are significant factors that can contribute to the growth of the specimen
collection cards market.
These factors play a crucial role in expanding the
adoption of advanced medical technologies and diagnostic solutions, including
specimen collection cards. In many emerging markets, remote and rural areas
have limited access to healthcare services. Specimen collection cards can be
easily transported and used in these areas, enabling patients to collect
samples at home and send them to central laboratories for testing. Emerging
markets often face challenges related to infectious disease outbreaks and
limited surveillance capabilities. Specimen collection cards can enable more
efficient and widespread collection of samples for surveillance and monitoring
purposes. As emerging markets invest in strengthening their healthcare systems,
specimen collection cards can play a role in capacity building by enabling
efficient and standardized sample collection and testing processes.
However, Regulatory Compliance and Standards and
Quality and Consistency are expected to slow down the growth of the market in
the coming years.
The Global Specimen Collection Cards Market segmentation
is based on Type, Material, Product, Application, Distribution Channel, By
End-User, By Company, and Region.
Some of the major companies operating in the Global Specimen Collection Cards Market include:
- Qiagen LLC
- Perkinelmer, Inc.
- DBS System SA
- Danaher Corporation
- Eastern Business Forms, Inc.
- Ahlstrom Oyj
- Archimed Life Science GmbH
- GenTegra LLC
- FortiusBio LLC
- Centogene N.V.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“Certain areas, particularly in the North
America, are projected to exert significant demand for Specimen Collection
Cards globally. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall wellbeing
of people each year, are expected to contribute to a remarkable growth of the Global
Specimen Collection Cards Market in the forecast period," said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based Global
management consulting firm.
Specimen Collection Cards Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented by Type (Blood, Saliva,
Urine, Buccal cells, others), By
Material (Cotton & Cellulose-based, Fiber-based, others), by Product
(Whatman 903, Ahlstrom 226, FTA, others), by Application (Newborn Screening
(NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics,
Research, Wellbeing/Health Monitoring, others), by Distribution Channel
(Online, Offline), By End User
(Hospitals & clinics, Diagnostics centers, others), By Region, Competition has evaluated the future growth potential of Global
Specimen Collection Cards Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
innovative market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Specimen
Collection Cards Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New York
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com